Sol-Gel Technologies Ltd. - (SLGL) closed at $68.19 on October 27, 2026, down 2.1% from the previous close, on volume of 37,927 shares (30-day average 43,647).
Data as of October 27, 2026.
No headlines found.
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
Globe Newswire (Wed, 30-Sep 9:14 AM ET)
Globe Newswire (Thu, 17-Sep 8:30 AM ET)
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Globe Newswire (Thu, 20-Aug 8:30 AM ET)
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Sol-Gel Technologies Ltd. - trades on the NASDAQ stock market under the symbol SLGL.
As of October 27, 2026, SLGL stock price declined to $68.19 with 37,927 million shares trading.
SLGL has a beta of 0.82, meaning it tends to be less sensitive to market movements. SLGL has a correlation of 0.02 to the broad based SPY ETF.
SLGL has a market cap of $223.25 million. This is considered a Small Cap stock.
Last quarter Sol-Gel Technologies Ltd. - reported $591,000 in Revenue and -$1.13 earnings per share. This beat revenue expectation by $441,000 and exceeded earnings estimates by $1.18.
In the last 3 years, SLGL traded as high as $97.97 and as low as $3.34.
The top ETF exchange traded funds that SLGL belongs to (by Net Assets): IZRL, QQQS.
SLGL has outperformed the market in the last year with a price return of +71.3% while the SPY ETF gained +13.4%. However, in the short term, SLGL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.6% vs +4.4% return in SPY. But in the last 2 weeks, SLGL shares have fared better than the market returning -0.2% compared to SPY -1.1%.
SLGL support price is $66.23 and resistance is $73.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLGL shares will trade within this expected range on the day.
